Loading company…
Riskpilot
← Back to search
Sign in
Get full access
7. marts 2024 ApS
APS
Bankrupt
CVR 41282002
Tjærbyvej 90
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2020
2 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2022
DKK -1,6M
-119% vs 2021
EBITDA margin
162.8%
-135% vs 2021
Equity ratio
51.6%
Financial strength
Net profit 2022
DKK -4,8M
-186% vs 2021
EBITDA — year on year
DKK millions
0M
2M
4M
7M
9M
2M
2020
7M
+250%
2021
-3M
-143%
2022
Key figures
Annual report 2022
Revenue
DKK -1,6M
-119%
EBITDA
DKK -2,6M
-135%
Net profit
DKK -4,8M
-186%
Total assets
DKK 3,6M
-57%
Equity
DKK 1,9M
-72%
Employees
2
—
Company information
Legal name
7. marts 2024 ApS
CVR number
41282002
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
6. april 2020
Share capital
DKK 40.000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Contact
Address
Tjærbyvej 90
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Randers
All Denmark companies
Revenue
DKK millions
0M
3M
5M
8M
10M
3M
2020
9M
2021
-2M
2022
EBITDA
DKK millions
0M
2M
4M
6M
8M
2M
2020
7M
2021
-3M
2022
Income statement
DKK thousands
Item
2020
2021
2022
Revenue
3.037
8.626
-1.601
Staff expenses
-803
-1.288
-1.004
EBITDA
2.234
7.339
-2.605
Depreciation & amort.
-0
-0
-0
EBIT
2.234
7.339
-2.605
Net financials
-4
-176
-2.752
Profit before tax
2.230
7.162
-5.357
Tax
463
1.601
-576
Net profit
1.766
5.561
-4.781
Balance sheet
DKK thousands
Item
2020
2021
2022
Total assets
5.528
8.474
3.628
Equity
1.806
6.652
1.871
Long-term debt
0
0
0
Short-term debt
3.722
1.822
1.757
Total debt
3.722
1.822
1.757
Financial ratios
5-year trend
EBITDA margin
-260507800.0%
This company
15.8%
Market median
-1648783644% vs market
2020
2022
Equity ratio
51.6%
This company
38.2%
Market median
+35% vs market
2020
2022
Return on equity
-255.5%
This company
18.4%
Market median
-1489% vs market
2020
2022
Net profit margin
-478073900.0%
This company
8.1%
Market median
-5902147014% vs market
2020
2022
Asset turnover
-0.44×
This company
1.12×
Market median
-139% vs market
2020
2022
Debt / equity
0.94×
This company
0.62×
Market median
+52% vs market
2020
2022
Annual reports & filings
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-04-06 – 2020-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
LT
Lars Thomas Kristensen
Management
Management
2020
—
—
IW
Ingo Walterscheid
Chief Executive Officer
Chief Executive Officer
2022
—
—
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
JS
Jørgen Skov
Board of Directors
2020
—
—
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Jens Hedemann Mortensen
Individual
10.0%
10.0%
2021
Revisor Innovation ApS
Company
10.0%
10.0%
2021
J. Hedemann Holding ApS
Company
10.0%
10.0%
2021
8. marts 2024 ApS
Company
100.0%
100.0%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of 7. marts 2024 ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Lars Thomas Kristensen
Management
0 companies
Ingo Walterscheid
Chief Executive Officer
0 companies
Jørgen Skov
Board of Directors
0 companies